Psoriasis is a systemic disease
New non-allergenic, anti-inflammatory fragrance could be game changer for dry skin sufferers
New evidence shows that systemic inflammation in psoriasis can be treated orally with a non-living strain of a commensal microbe
New Research Reveals that Risky Sexual Behaviour and STIs are on the Rise Despite COVID-19 Pandemic
New analysis reveals ‘long-hauler’ COVID-19 patients with prolonged skin symptoms - Lessons from the International COVID-19 Dermatology Registry
Urban living decreases skin bacterial diversity and why is it a problem
Contact dermatitis: New allergens
Hidradenitis suppurativa
Moderate psoriasis: a journey towards patient-centred care
Emerging treatments for onychomycosis
Primay results on acne exposome: real life data
Safety and efficacy of the oral JAK3/TEC inhibitor PF-06651600 and the oral TYK2/JAK1 inhibitor PF-06700841 in a withdrawal/retreatment extension study in patients with alopecia areata
Highlights of the laser session at EADV 2019
International landscape of therapies in CTCL
Molecular resistance to targeted therapy, from bench to bedside
When instruments are not enough, clinical clues are needed